Essity AB (FRA:ESWB)
€ 27.93 0.29 (1.05%) Market Cap: 19.09 Bil Enterprise Value: 23.56 Bil PE Ratio: 11.59 PB Ratio: 2.65 GF Score: 75/100

Half Year 2024 Essity AB (publ) Earnings Call Transcript

Jul 18, 2024 / 07:00AM GMT
Release Date Price: €25.45 (+5.73%)

Key Points

Positve
  • Essity AB (ETTYF) achieved its highest EBITDA operating result to date, with a 17% increase, reaching SEK 3.4 billion.
  • The company announced a share buyback program amounting to SEK 3 billion, indicating strong operating cash flow.
  • Health and Medical segment showed strong development with organic sales growth of 4.5%, driven by both volume and price/mix improvements.
  • Consumer goods segment saw higher volumes in all categories, with incontinence products retail increasing by 9.7%.
  • Professional Hygiene segment reported higher EBITDA margin and positive volume growth excluding restructuring impacts.
Negative
  • Organic sales growth was slightly down by 0.9%, indicating some challenges in maintaining sales momentum.
  • Consumer Tissue experienced a negative price mix of 4.5%, impacting overall organic sales growth in the consumer goods segment.
  • The company faces a subdued consumer environment with down-trading and a focus on savings, which could impact future sales.
  • Raw material costs, particularly pulp, are expected to increase, potentially putting pressure on margins in the coming quarters.
  • Professional Hygiene segment's organic sales growth was down by 3.9%, with volumes negatively impacted by restructuring.
Sandra Aberg;publ;Vice President;Investor Relations
Essity AB

()--

Yes, good morning and very welcome to Essity audio presentation of second quarter 2024 results. My name is Sandra Aberg, Head of Investor Relations. And Joining today are CEO, Magnus Groth, and our CFO, Fredrik Rystedt. Magnus and Fredrik will take us through the results after that, you are very welcome with your questions.

Now I leave the line over to you, Magnus, please.

Magnus Groth;publ;President
Essity AB;Chief Executive Officer, Director

()- -

Thank you, Sandra, and welcome, everyone, to our Q2 interim report 2024 and assets summary, equity had a strong performance in the second quarter with high underlying volume growth, our highest EBITDA operating result to date with higher margins in all three business areas. We continued to show solid cash flow. And not to forget that during the quarter we announced a share buyback program and new ambitious financial targets.

So summing up the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot